The Efficacy of the BCG Vaccine against Newly Emerging Clinical Strains of Mycobacterium tuberculosis

Marcela Henao-Tamayo; Crystal A. Shanley; Deepshikha Verma; Andrew Zilavy; Margaret C. Stapleton; Synthia K. Furney; Brendan Podell; Ian M. Orme

doi:10.1371/journal.pone.0136500

Loading metrics

Open Access

Peer-reviewed

Research Article

The Efficacy of the BCG Vaccine against Newly Emerging Clinical Strains of Mycobacterium tuberculosis

Marcela Henao-Tamayo,

Affiliation Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, United States of America
⨯
Crystal A. Shanley,

Affiliation Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, United States of America
⨯
Deepshikha Verma,

Affiliation Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, United States of America
⨯
Andrew Zilavy,

Affiliation Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, United States of America
⨯
Margaret C. Stapleton,

Affiliation Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, United States of America
⨯
Synthia K. Furney,

Affiliation Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, United States of America
⨯
Brendan Podell,

Affiliation Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, United States of America
⨯
Ian M. Orme

* E-mail: ian.orme@colostate.edu

Affiliation Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, United States of America
⨯

The Efficacy of the BCG Vaccine against Newly Emerging Clinical Strains of Mycobacterium tuberculosis

Marcela Henao-Tamayo,
Crystal A. Shanley,
Deepshikha Verma,
Andrew Zilavy,
Margaret C. Stapleton,
Synthia K. Furney,
Brendan Podell,
Ian M. Orme

Published: September 14, 2015
https://doi.org/10.1371/journal.pone.0136500

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Guinea pigs
Is the Subject Area "Guinea pigs" applicable to this article?

Thanks for your feedback.
Vaccination and immunization
Is the Subject Area "Vaccination and immunization" applicable to this article?

Thanks for your feedback.
HIV vaccines
Is the Subject Area "HIV vaccines" applicable to this article?

Thanks for your feedback.
Vaccine development
Is the Subject Area "Vaccine development" applicable to this article?

Thanks for your feedback.
Mouse models
Is the Subject Area "Mouse models" applicable to this article?

Thanks for your feedback.
Recombinant vaccines
Is the Subject Area "Recombinant vaccines" applicable to this article?

Thanks for your feedback.
Aerosols
Is the Subject Area "Aerosols" applicable to this article?

Thanks for your feedback.
Animal models
Is the Subject Area "Animal models" applicable to this article?

Thanks for your feedback.